Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1984-08-02
1988-10-04
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514800, A61K 3743
Patent
active
047756608
ABSTRACT:
A method of treatment of breast cancer in susceptible animals whose ovarian hormonal secretions were previously blocked by surgical or chemical means, e.g., by use of an LH-RH agonist, e.g., [D-Trp.sup.6, des-Gly-NH.sub.2.sup.10 ]LH-RH ethylamide with a combination therapy comprising administering an antiandrogen, e.g., flutamide and an antiestrogen, e.g., Tamoxifen, pharmaceutical compositions useful for such treatment and two and three component pharmaceutical kits containing such compositions are disclosed.
REFERENCES:
patent: 4024248 (1977-05-01), Konig et al.
patent: 4071622 (1978-01-01), Johnson et al.
patent: 4094994 (1978-06-01), Schonenberger et al.
patent: 4097578 (1978-06-01), Perronnet et al.
patent: 4118483 (1978-10-01), Konig et al.
patent: 4329364 (1982-05-01), Neri et al.
patent: 4472382 (1984-09-01), Labrie et al.
patent: 4666885 (1987-05-01), Labrie
Miller et al., Nature, 313 (1985), pp. 231-233.
Cancer Treatment Reports, vol. 68 (No. 1), pp. 281-289 (1984), A. V. Schally et al.
Proc. Natl. Acad. Sci. USA., vol. 80, pp. 1459-1462 (1983), T. W. Redding and A. V. Schally.
"LH-RH Analogs in the Treatment of Human Breast Cancer", H. A. Harvey et al. in LHRH and Its Analogs--A New Class of Contraceptive and Therapeutic Agents, (R. H. Vickery et al., eds), MTP Press, Lancaster, U. K. (1984), pp. 329-335.
Lancet, 1, 1213-1216 (1982), J. G. M. Klijn et al. (The Lancet, May 29, 1982).
Cancer, vol. 50, 1708-1712 (1982), A. V. Buzdar et al.
Lancet, 1204-1207 (1973), H. Flax et al., (The Lancet; Jun. 2, 1973).
The Prostate, vol. 4, 579-594 (1983), F. Labrie et al.
J. Steroid Biochem., vol. 19, 99-1007 (1983), F. Labrie et al.
Cancer Treatment Review, vol. 5, 131-141 (1978), H. Movridsen et al.
J. Steroid Biochem., vol. 20 (No. 6B), 1381 (1984), J. G. M. Klijn et al.
J. Med. Chem., vol. 21, 1018-1024 (1978), A. S. Dutta et al.
Biochem. Biophy. Res. Commun., vol. 100, pp. 915-920 (1981), J. Erchegyi et al.
Endrocrinology, vol. 110, pp. 1445-1447 (1982); D. H. Coy et al.
J. Steroid. Biochem., vol. 20 (No. 6B), 1366 (1984); J. J. Nestor et al.
J. Steroid Biochem., vol. 20 (No. 6B), 1365 (1984); J. Rivier et al.
J. Steroid. Biochem., vol. 20 (No. 6B), p. 1369 (1984); A. Corbin et al.
"Solid Phase Peptide Synthesis", Stewart et al., Freeman et al., San Francisco, CA (1969), pp. 1-26.
J. Med. Chem., vol. 19, pp. 423-425 (1976), D. H. Coy et al.
Belanger Alain
Dupont Andre
Labrie Fernand
LandOfFree
Treatment of breast cancer by combination therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of breast cancer by combination therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of breast cancer by combination therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2156471